UnitedHealth Group (UNH) has become a focus for many hedge funds, Wall Street professionals, and even some members of Congress. This large healthcare company, known for its health insurance services, has recently seen its stock price drop by more than 50% this year. Despite this, some experts believe there may be a chance for recovery.
What Caused the Drop?
The main reason for the decline in UnitedHealth’s stock is rising medical costs. These costs have eaten into the company’s profits. One important measure, called the medical loss ratio, shows how much of the money collected from insurance premiums is spent on paying claims. When this number gets too high, profits fall. In the second quarter of this year, UnitedHealth missed its earnings expectations and had to lower its profit forecast for the rest of the year.
There are also other challenges. The company faces higher costs for Medicare Advantage plans, which are government-backed insurance plans for older adults. On top of that, the U.S. Department of Justice is investigating UnitedHealth’s Medicare Advantage program, adding more uncertainty for investors. The previous CEO resigned, and this has made some people even more worried.
Insider Buying: A Positive Sign?
Despite these problems, there are signs that some insiders believe the worst may be over. In May 2025, the new CEO, Stephen J. Hemsley, bought $25 million worth of UnitedHealth stock. Another executive also bought $5 million. Insider buying like this is rare and often seen as a sign that those running the company think the stock is undervalued and could go up.
Is UnitedHealth Undervalued?
UnitedHealth is a huge company, with $400 billion in yearly revenue. Its stock is now trading at a low price compared to its earnings, which some investors call a low “forward PE ratio.” This means the stock might be cheap compared to how much money the company is expected to make in the future.
Some financial charts show that UnitedHealth’s profits and free cash flow (the money left after paying expenses) have dropped, but there are early signs of improvement. The company’s management plans to raise insurance premiums and cut costs starting in 2026, which could help profits recover.
Risks to Consider
There are still risks. Medical costs are likely to stay high for a while, and profits may not grow until 2026. Some analysts think the stock could fall even further. The ongoing government investigation could also lead to fines or changes in how the company does business.
Investors often use tools like the Relative Strength Index (RSI) to see if a stock is “oversold,” meaning it might be undervalued. UnitedHealth’s RSI is currently low, but stocks can stay oversold for a long time.
What Should Investors Watch?
Experts suggest watching for signs that UnitedHealth is starting to recover. This could include the stock price moving above certain “moving average” lines, which are used to spot trends. If the company’s performance improves compared to its competitors, that could also be a good sign.
The Bigger Picture
The stock market as a whole is facing challenges. Many sectors are not doing well, and it may be harder to make easy profits. Investors should be careful, set limits on their losses, and pay attention to news and trends.
For those interested in learning more about Felix Prehn and his approach to investing, visit the Felix Prehn Goat Academy page.